ScienceDaily: Engineering and Construction News |
- Drug-infused nanoparticle is right for sore eyes
- Smallest world record has ‘endless possibilities’ for bio-nanotechnology
- Demanding ITER operation successful: Fusion reactor cassette collecting impurities replaced via remote control method
Drug-infused nanoparticle is right for sore eyes Posted: 08 Oct 2014 05:40 PM PDT For the millions of sufferers of dry eye syndrome, their only recourse to easing the painful condition is to use drug-laced eye drops three times a day. Now, researchers have developed a topical solution containing nanoparticles that will combat dry eye syndrome with only one application a week. |
Smallest world record has ‘endless possibilities’ for bio-nanotechnology Posted: 08 Oct 2014 05:35 AM PDT Scientists have taken a crucial step forward in bio-nanotechnology, a field that uses biology to develop new tools for science, technology and medicine. The new study demonstrates how stable 'lipid membranes' -- the thin 'skin' that surrounds all biological cells -- can be applied to synthetic surfaces. Importantly, the new technique can use these lipid membranes to 'draw' -- akin to using them like a biological ink -- with a resolution of 6 nanometres (6 billionths of a meter), which is much smaller than scientists had previously thought was possible. |
Posted: 06 Oct 2014 05:49 AM PDT Engineers have reached an important objective in the development of ITER fusion reactor remote control, when the divertor cassette was replaced for the first time using remote control in the research facility for remote controlled maintenance. This operation is one of the most demanding measures in the forthcoming ITER fusion reactor, the construction of which is proceeding rapidly in Gadarache, Southern France. |
You are subscribed to email updates from Engineering and Construction News -- ScienceDaily To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google Inc., 20 West Kinzie, Chicago IL USA 60610 |
No comments:
Post a Comment